Exclusives Archives - Page 51 of 102

1 minute read

EXCLUSIVE: Data Monitoring Committee Allows BioRestorative’s Chronic Lumbar Disc Disease To Continue Unchanged

June 27, 6:30 AM

BioRestorative Therapies Inc (NASDAQ: BRTX) has announced that the independent Data Safety Monitoring Board (DSMB), overseeing the company's ongoing Phase 2 trial to treat chronic lumbar disc disease, unanimously recommended the continuation of the study under the current version of the protocol wi

BRTX

2 minute read

Musk Vs. Zuckerberg: Benzinga Users Favor One Billionaire If Biggest Fight In ‘History Of The World’ Happens

By Chris Katje

June 26, 12:23 PM

A feud between two billionaires could be spilling over to an official cage match. Sportsbooks have placed early odds on who would win between Elon Musk and Mark Zuckerberg in the ring. Here’s a look at who Benzinga users see winning the match if it happens.

DKNG

2 minute read

EXCLUSIVE: Prenetics, Professor Dennis Lo Aim To Make Early Cancer Detection ‘Universally Accessible Necessity’ With $200M Joint Venture

By Bibhu Pattnaik

June 25, 8:30 PM

Prenetics Global Limited (NASDAQ: PRE), a genomics and precision oncology company, and Professor Dennis Lo announced Sunday they have entered a partnership to establish an early cancer detection screening joint venture, Insighta.

PRE

3 minute read

EXCLUSIVE: Axie Infinity’s Jihoz Discusses GameFi Success and Future Plans at Crypto Unlocked

By Jose Rodrigo Safdiye

June 25, 6:00 PM

In an enlightening interview hosted by Justin Roberti and myself, J Rod Safdiye, at the Benzinga Crypto Unlocked virtual event, we dove deep into the future of Web3 gaming with

AXS

3 minute read

Video: ‘Moms On Mushrooms Are Gonna Change The Whole Society,’ Says Zappy Zapolin Before Presenting Rick Doblin Award

By Javier Hasse

June 23, 3:36 PM

In a moment of riveting candor at MAPS' Psychedelic Science 2023 conference in Denver, Colorado, Benzinga Cannabis' Lara Goldstein captured the potent essence of Psycheceutical Bioscience Inc (OTC:

BWVI

1 minute read

From Fidget Spinners To Fintech Success: This Young Entrepreneur Is Changing How Gen Z Invests

By Aaron Bry

June 23, 2:02 PM

Allan Maman got his business career started early, creating Fidget360 while he was still in high school. Maman credits, at least partially, Fidget360 for starting the fidget spinner fad of 2017-2018.

HOOD

3 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

By Chris Katje

June 23, 10:28 AM

Investors are on the hunt for undervalued, underfollowed and emerging stocks, and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

BTC

2 minute read

How Can Uber And Leafly Help Take Cannabis Consumers From Unlicensed To Legal Market?

By Javier Hasse

June 22, 3:34 PM

In a lively discussion at the recent Benzinga Cannabis Capital Conference in Miami, Leafly (NASDAQ: LFLY) CEO Yoko Miyashita didn't hesitate to lay down the stakes of the industry'

LFLY

1 minute read

EXCLUSIVE: Alzamend Neuro Identifies Potential AL001 Dose Level For Upcoming Alzheimer’s Study

By Vandana Singh

June 22, 7:30 AM

Alzamend Neuro Inc (NASDAQ: ALZN) has identified a maximum tolerated dose (MTD) for developing AL001 from a multiple-ascending dose study as assessed by an independent safety review committee.

ALZN

1 minute read

EXCLUSIVE: SciSparc’s Tourette Syndrome Candidate Receives IRB Approval To Start Phase 2b Study In US

By Vandana Singh

June 21, 8:30 AM

SciSparc Ltd (NASDAQ: SPRC) has received Institutional Review Board (IRB) approval for its Phase 2b clinical trial for SCI-110 in subjects suffering from Tourette Syndrome. Tourette Syndrome is a nervous system condition in which people have "tics."

SPRC